With the passage of the farm bill, the expansion of cannabinoids from Hemp, and the rapidly growing interest in the long-standing therapeutic value of mushrooms, this session will walk through what the future of natural health products can look like for these emerging products. As well as a discussion about the most plausible timeline for when the FDA will move ahead with CBD regulation

Chris Murray
Principal - FoxNRTH Inc.
Nature’s Controlled Substances: Cannabinoids, Adaptogens & the FDA
About Chris Murray
Chris Murray is the Founder for FoxNRTH Inc. a boutique shop providing businesses, regulatory & strategic consulting through the lens of systems theory. Prior to launching FoxNRTH, Chris was one of the founding employees of Canopy Growth Corporation, he held multiple roles as a Vice President. Chris was responsible for establishing the first Medical Marijuana Direct to Physician outreach program, expanding clinic development across Canada, securing $2.2 MM in subsidies from the State of Victoria in Australia for market expansion, and successfully facilitating the export of Cannabis from Canada to the USA.
Chris served as the founding Director of Strategic Growth for Fullscript Natural Partners, a company that allows integrative health professionals to create their own virtual dispensary to prescribe health products to their patients. Chris is a strategic advisor to several companies in the health and wellness space including Fullscript, Triage, Prosperity Farms, Hyasynth Bio, & Forage Hyperfoods.